MONITORING VORICONAZOLE PHARMACOGENOMICS AND PLASMA CONCENTRATIONS IN THE TREATMENT AND PREVENTION OF INVASIVE FUNGAL DISEASE FOR HEMATOLOGICAL PATIENTS A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Guo, D. [1 ]
Xu, T. [1 ]
Li, Z. [1 ]
Yin, J. [1 ]
Tian, X. [1 ]
Guo, D. [1 ]
Xu, Y. [1 ]
Zhu, X. [1 ]
Miao, L. [1 ]
Wu, D. [1 ,2 ]
Tang, X. [1 ,2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1152
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [1] Monitoring voriconazole pharmacogenomics and plasma concentrations in the treatment and prevention of invasive fungal disease for hematological patients:-a single center experience
    Guo, X. T. D.
    Li, J. Y. Z.
    Tian, D. G. X.
    Xu, X. Z. Y.
    Miao, D. W. L.
    Xiaoawen, T.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S114 - S115
  • [2] Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients
    Tang, XiaoWen
    Qu, Honglan
    Guo, Dandan
    Xu, Ting
    Dai, Haiping
    Li, Zheng
    Yin, Jia
    Tian, Xiaopeng
    Guo, Danqing
    Xu, Yang
    Zhu, Xiaming
    Miao, Liyan
    Wu, Depei
    [J]. BLOOD, 2017, 130
  • [3] CYP2C19 genetic polymorphism and monitoring voriconazole plasma concentrations in the treatment and prevention of invasive fungal disease for hematological patients
    曲洪澜
    [J]. China Medical Abstracts (Internal Medicine), 2018, 35 (02) : 118 - 119
  • [4] Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections
    Kim, Do-Young
    Park, Hyo Jung
    Lee, Yu Jeung
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (03) : 209 - 216
  • [5] PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - RESULTS FROM A SINGLE HEMATOLOGICAL CENTRE
    Ivanyi, J. L.
    Plander, M.
    Szendrei, T.
    Toth, C.
    [J]. HAEMATOLOGICA, 2016, 101 : 765 - 765
  • [6] Isavuconazole for the prophylaxis and treatment of invasive fungal disease: A single-center experience
    Vu, Christine A.
    Rana, Meenakshi M.
    Jacobs, Samantha E.
    Saunders-Hao, Patricia
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
  • [7] Impact of pharmacogenetic on voriconazole plasma concentration in patients with invasive fungal disease
    Allegra, S.
    Fatiguso, G.
    De Francia, S.
    Arduino, A.
    Favata, F.
    Di Perri, G.
    D'Avolio, A.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 684 - 685
  • [8] Experience in pharmacokinetic monitoring of posaconazole as prophylaxis of invasive fungal infection in hematological patients
    Pena-Lorenzo, D.
    Rebollo, N.
    Sanchez-Hernandez, J. G.
    Zarzuelo-Castaneda, A.
    Perez-Blanco, S.
    Garcia-Casanueva, J. C.
    Vazquez-Lopez, L.
    Otero, M. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1537 - 1537
  • [9] Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience
    Simone Cesaro
    Liliana Strugo
    Rita Alaggio
    Giovanni Cecchetto
    Luca Rigobello
    Marta Pillon
    Riccardo Cusinato
    Luigi Zanesco
    [J]. Supportive Care in Cancer, 2003, 11 : 722 - 727
  • [10] Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience
    Cesaro, S
    Strugo, L
    Alaggio, R
    Cecchetto, G
    Rigobello, L
    Pillon, M
    Cusinato, R
    Zanesco, L
    [J]. SUPPORTIVE CARE IN CANCER, 2003, 11 (11) : 722 - 727
12345